129 related articles for article (PubMed ID: 2063881)
21. Effect of non-heparin thrombin antagonists on thrombin generation, platelet function, and clot structure in whole blood.
Carr ME; Angchaisuksiri P; Carr SL; Martin EJ
Cell Biochem Biophys; 2003; 39(2):89-99. PubMed ID: 14515016
[TBL] [Abstract][Full Text] [Related]
22. A novel, quantitative clot retraction assay to evaluate platelet function.
Muraoka WT; Nair PM; Darlington DN; Wu X; Bynum JA; Cap AP
Platelets; 2023 Dec; 34(1):2254403. PubMed ID: 37700390
[TBL] [Abstract][Full Text] [Related]
23. Interplay of Platelet Contractility and Elasticity of Fibrin/Erythrocytes in Blood Clot Retraction.
Tutwiler V; Wang H; Litvinov RI; Weisel JW; Shenoy VB
Biophys J; 2017 Feb; 112(4):714-723. PubMed ID: 28256231
[TBL] [Abstract][Full Text] [Related]
24. Quantitative assessment of platelet function and clot structure in patients with severe coronary artery disease.
Greilich PE; Carr ME; Zekert SL; Dent RM
Am J Med Sci; 1994 Jan; 307(1):15-20. PubMed ID: 8291501
[TBL] [Abstract][Full Text] [Related]
25. Effects of recombinant factor VIIa on platelet function and clot structure in blood with deficient prothrombin conversion.
Carr ME; Martin EJ; Kuhn JG; Seremetis SV
Thromb Haemost; 2003 May; 89(5):803-11. PubMed ID: 12719776
[TBL] [Abstract][Full Text] [Related]
26. Role of platelets in lysis of dilute plasma clots: requirement for metabolically active platelets.
Lockhart MS; Comp PC; Taylor FB
J Lab Clin Med; 1979 Aug; 94(2):285-94. PubMed ID: 458246
[TBL] [Abstract][Full Text] [Related]
27. Effects of ionic and nonionic contrast media on clot structure, platelet function and thrombolysis mediated by tissue plasminogen activator in plasma clots.
Carr ME; Carr SL; Merten SR
Haemostasis; 1995; 25(4):172-81. PubMed ID: 7557656
[TBL] [Abstract][Full Text] [Related]
28. Glycoprotein IIb/IIIa blockade inhibits platelet-mediated force development and reduces gel elastic modulus.
Carr ME; Carr SL; Hantgan RR; Braaten J
Thromb Haemost; 1995 Mar; 73(3):499-505. PubMed ID: 7667835
[TBL] [Abstract][Full Text] [Related]
29. Molecular mechanisms of fibrin gel clot retraction by platelets and cultured tumor cells.
Tanoue K; Katagiri Y; Suzuki H
Pol J Pharmacol; 1996; 48(3):341-3. PubMed ID: 9112674
[TBL] [Abstract][Full Text] [Related]
30. Mechanics and contraction dynamics of single platelets and implications for clot stiffening.
Lam WA; Chaudhuri O; Crow A; Webster KD; Li TD; Kita A; Huang J; Fletcher DA
Nat Mater; 2011 Jan; 10(1):61-6. PubMed ID: 21131961
[TBL] [Abstract][Full Text] [Related]
31. Chitosan inhibits platelet-mediated clot retraction, increases platelet-derived growth factor release, and increases residence time and bioactivity of platelet-rich plasma in vivo.
Deprés-Tremblay G; Chevrier A; Tran-Khanh N; Nelea M; Buschmann MD
Biomed Mater; 2017 Nov; 13(1):015005. PubMed ID: 29125132
[TBL] [Abstract][Full Text] [Related]
32. Platelets and fibrin strands during clot retraction.
Morgenstern E; Korell U; Richter J
Thromb Res; 1984 Mar; 33(6):617-23. PubMed ID: 6539004
[TBL] [Abstract][Full Text] [Related]
33. Plasminogen, plasminogen activator, and platelets in the regulation of clot lysis. Reconstitution and patient studies.
Carroll RC; Radcliffe RD; Taylor FB; Gerrard JM
J Lab Clin Med; 1982 Dec; 100(6):986-96. PubMed ID: 6890569
[TBL] [Abstract][Full Text] [Related]
34. The platelet strip. I. A low-fibrin contractile model of thrombin-activated platelets.
Salganicoff L; Loughnane MH; Sevy RW; Russo M
Am J Physiol; 1985 Sep; 249(3 Pt 1):C279-87. PubMed ID: 3898863
[TBL] [Abstract][Full Text] [Related]
35. Clinically relevant HOCl concentrations reduce clot retraction rate via the inhibition of energy production in platelet mitochondria.
Misztal T; Rusak T; Tomasiak M
Free Radic Res; 2014 Dec; 48(12):1443-53. PubMed ID: 25236568
[TBL] [Abstract][Full Text] [Related]
36. Examining platelet-fibrin interactions during traumatic shock in a swine model using platelet contractile force and clot elastic modulus.
White NJ; Martin EJ; Brophy DF; Ward KR
Blood Coagul Fibrinolysis; 2011 Jul; 22(5):379-87. PubMed ID: 21537163
[TBL] [Abstract][Full Text] [Related]
37. [Evaluation of thrombocyte retractile activity using a retractograph].
Shitikova AS; Levitina DI; Galushkin AN; Shifrin LI
Lab Delo; 1990; (7):49-53. PubMed ID: 1699070
[TBL] [Abstract][Full Text] [Related]
38. Peroxynitrite may affect fibrinolysis via the reduction of platelet-related fibrinolysis resistance and alteration of clot structure.
Misztal T; Rusak T; Brańska-Januszewska J; Ostrowska H; Tomasiak M
Free Radic Biol Med; 2015 Dec; 89():533-47. PubMed ID: 26454084
[TBL] [Abstract][Full Text] [Related]
39. Peroxynitrite may affect clot retraction in human blood through the inhibition of platelet mitochondrial energy production.
Misztal T; Rusak T; Tomasiak M
Thromb Res; 2014 Mar; 133(3):402-11. PubMed ID: 24388569
[TBL] [Abstract][Full Text] [Related]
40. Development of platelet contractile force as a research and clinical measure of platelet function.
Carr ME
Cell Biochem Biophys; 2003; 38(1):55-78. PubMed ID: 12663942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
